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Abstract
Background: Existing smoking cessation treatments are challenged by low engagement and high relapse rates, suggesting the
need for more innovative, accessible, and interactive treatment strategies. Twitter is a Web-based platform that allows people to
communicate with each other throughout the day using their phone.
Objective: This study aims to leverage the social media platform of Twitter for fostering peer-to-peer support to decrease relapse
with quitting smoking. Furthermore, the study will compare the effects of coed versus women-only groups on women’s success
with quitting smoking.
Methods: The study design is a Web-based three-arm randomized controlled trial with two treatment arms (a coed or women-only
Twitter support group) and a control arm. Participants are recruited online and are randomized to one of the conditions. All
participants will receive 8 weeks of combination nicotine replacement therapy (patches plus their choice of gum or lozenges),
serial emails with links to Smokefree.gov quit guides, and instructions to record their quit date online (and to quit smoking on
that date) on a date falling within a week of initiation of the study. Participants randomized to a treatment arm are placed in a
fully automated Twitter support group (coed or women-only), paired with a buddy (matched on age, gender, location, and
education), and encouraged to communicate with the group and buddy via daily tweeted discussion topics and daily automated
feedback texts (a positive tweet if they tweet and an encouraging tweet if they miss tweeting). Recruited online from across the
continental United States, the sample consists of 215 male and 745 female current cigarette smokers wanting to quit, aged between
21 and 59 years. Self-assessed follow-up surveys are completed online at 1, 3, and 6 months after the date they selected to quit
smoking, with salivary cotinine validation at 3 and 6 months. The primary outcome is sustained biochemically confirmed abstinence
at the 6-month follow-up.
Results: From November 2016 to September 2018, 960 participants in 36 groups have been recruited for the randomized
controlled trial, in addition to 20 participants in an initial pilot group. Data analysis will commence soon for the randomized
controlled trial based on data from 896 of the 960 participants (93.3%), with 56 participants lost to follow-up and 8 dropouts.
Conclusions: This study combines the mobile platform of Twitter with a support group for quitting smoking. Findings will
inform the efficacy of virtual peer-to-peer support groups for quitting smoking and potentially elucidate gender differences in
quit rates found in prior research.
Trial Registration: Clinicaltrials.gov NCT02823028; https://clinicaltrials.gov/ct2/show/NCT02823028.
International Registered Report Identifier (IRRID): DERR1-10.2196/16417
JMIR Res Protoc 2019 | vol. 8 | iss. 12 | e16417 | p. 1http://www.researchprotocols.org/2019/12/e16417/
(page number not for citation purposes)
Pechmann et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
(JMIR Res Protoc 2019;8(12):e16417)  doi: 10.2196/16417
KEYWORDS
smoking prevention; support group; cigarettes; tobacco
Introduction
Background
State tobacco quitlines have demonstrated efficacy but remain
underutilized, reaching an average of only 1% of smokers
annually [1]. Dozens of randomized controlled trials have
examined websites with advanced features such as QuitNet
[2,3], or one-way SMS text messaging or email messaging
services such as txt2stop [4,5], but these interventions are limited
by information exchanges that are largely unilateral,
noninteractive, and nonpeer-based. Notably, although the initial
results of one-way messaging services for smoking cessation
looked promising [4,6-8], a recent review found that only 3 of
15 randomized trials showed significant benefits [9].
To increase utilization of quit-smoking programs, researchers
and practitioners are seeking to harness the power of social
media [10]. Very popular social media sites such as Facebook
and Twitter allow users to stay connected to individuals and
groups in real time and to share content at virtually no cost [11].
Social media is entrenched in the United States with 73% of
online adults using social media sites, 42% using multiple sites,
and the majority visiting them daily [12]. Twitter has a reported
326 million active users (100 million daily) posting 500 million
tweets daily, with 80% using the platform on their phone in
2018 [13]. There are already over 140 reported medical and
health care uses of Twitter [14]. Relative to Facebook, Twitter
has a superior application programming interface, which makes
it easier to create programs for research and intervention
purposes [15]. In addition, Twitter does a much better job of
ensuring that group member communications stay within the
group only by readily allowing for private groups to be set up
that are completely and permanently isolated from friends,
family, and the public.
Objectives
Social media looks highly promising for delivering tobacco and
other addiction treatment interventions as a result of its broad
reach and appeal, real-time interactivity, and free cost. However,
despite its apparent promise and observational evidence
indicating that existing socially mediated forums may increase
patient compliance [16], social media’s potential for delivering
health interventions and developing new treatment approaches
has not yet been fully realized. The earliest forms of social
media interventions tended to be large online health forums,
and these generally did not yield significant benefits [17-21],
although the people who were actively engaged did often benefit
[22]. Thus, the main problem with prior social media
interventions seems to be that engagement was too low [23].
Our Twitter-based intervention called Tweet2Quit tests and
improves a socially mediated intervention that already has been
shown to produce good engagement [24]. We believe that
engagement happens because of the development of a sense of
online community through extensive interpersonal and,
especially, dyadic interactions [25,26]. In response to calls for
the application of systems science to public health [27], we will
apply network analysis to examine tie strength among buddies
(paired people in the group based on similarity in age, gender,
location, and education) [28] and to identify social brokers
(people who facilitate communication between otherwise
unconnected individuals) [29].
Our first primary aim is to test the 6-month efficacy of
Tweet2Quit with biochemical verification of abstinence. We
hypothesize that relative to control coed (male and female)
groups (n=240), Tweet2Quit coed groups (n=480) will achieve
significantly greater bioconfirmed sustained abstinence at
6-months follow-up. Our second primary aim is to test whether
women do better in Tweet2Quit women-only versus coed
groups. We hypothesize that women will achieve significantly
greater bioconfirmed 6-month abstinence in Tweet2Quit
woman-only groups (n=240) versus Tweet2Quit coed groups
(n=240 women), as people tend to form stronger social
connections with others who share their defining characteristics
such as gender [30]. Secondary aims will test the same
hypotheses but based on 3-month (end of treatment) sustained
and bioconfirmed abstinence, and we will also test 7-day point
prevalence abstinence at 1, 3, and 6 months.
Exploratory aims will study the Tweet2Quit groups’ social
network structures with a focus on the buddy pairs and the
identification of social brokers (group members who facilitate
interaction between otherwise unconnected individuals), using
both baseline theoretically based measures and observed
tweeting behaviors. We predict that active buddies in the group
will enhance tie strength, among both buddy-partner ties and
partner-group ties, which will increase smoking abstinence. We
also predict that better social brokers will enhance tie strength,
as they will encourage more people to engage in the intervention
(tweet their group), which will increase smoking abstinence.
Methods
Study Setting
The study setting is virtual—hosted online via the study website
and Twitter—but the study is conducted by the University of
California, Irvine (UCI).
Trial Design
The study runs parallel groups, with treatment and control
groups starting and stopping at the same time. Treatment group
(n=20) and control group (n=10) allocation began once 30
participants passed screening, using a 2:1 ratio (see the
Randomization section below).
Inclusion Criteria
Participants are considered eligible if they are aged between 21
and 59 years (21 years being the strictest minimum age to
receive nicotine replacement therapy [NRT] products in the
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United States); speak English, so they are able to communicate
with their group; are current smokers (have smoked at least 100
cigarettes in their lifetime and are smoking at least five cigarettes
a day) to meet the requirement for NRT products; have a mobile
phone with an unlimited texting plan (unlimited data not
required) and internet to receive intervention messages; have
an active email account to receive quit-smoking guides; live in
the continental United States, so that all participants are in a
similar time zone to facilitate communication; can send/receive
SMS text messages at least once a week; and have an active
social media account to show they are familiar with and can
communicate on this platform.
Exclusion Criteria
Due to use of NRT in this study, participants are ineligible if
they have contraindications for NRT including irregular
heartbeat, high blood pressure not controlled with medication,
recent heart attack, pregnant or breast feeding, skin allergies to
adhesive tape, or serious skin problems [31]. Consistent with
other quit-smoking trials, those who do not want to set a quit
date or are not intending to quit in the next 30 days are excluded
[31]. As this social media intervention uses a peer-to-peer
support model, without a formal group moderator, and because
this is an initial demonstration trial, individuals taking medicine
for depression, using an illicit drug, or regularly using marijuana
are excluded [32]. For study retention, personal contact
information is required as is email verification. Those who fail
to provide these contact details, or who provide nonworking
phone numbers or emails, are excluded [33]. As we want to
conduct saliva tests using webcams, that is, cameras on mobile
phones, participants must show us they have this. To prevent
problems with misrepresentation, those who fail the screening
survey in the past are, henceforth, excluded. To prevent
problems with contamination, we exclude those who already
take medication for quitting smoking, who have participated in
the 2011-2014 Tweet2Quit study [34], or who live with someone
or have an immediate relative who has already participated or
will participate in the current Tweet2Quit study.
Electronic Cigarettes/Vaping
Electronic cigarettes (e-cigarettes)/vaping are discouraged during
the course of the program but are not forbidden, and participants
are not disqualified if these products are used. During the
follow-up surveys, participants are asked about the use of
e-cigarettes/vaping to include in the analyses.
Treatment (Twitter) Arms: Coed and Women-Only
The treatment participants are put into a private Twitter group
of 20 participants as well as paired with another participant in
the group for a buddy system. These participants are encouraged
to tweet (message) each other daily for support by logging into
a Twitter account that we provide to them free of charge, and
they receive a daily discussion topic as a tweet to help start
conversations. The discussion topics encourage participants to
get to know each other, express their quitting goals, and share
tips on how to stay smoke free. Participants are encouraged to
send at least one tweet a day, and their participation is monitored
automatically by the program.
In addition, treatment participants receive daily automated texts
providing feedback on their prior-day tweeting behavior, which
praises tweeters and encourages nontweeters to engage. If the
number of tweets over consecutive days falls below the
minimum expected (varies per week; decreases as the group
goes on), an additional text is sent to get participants onto
Twitter to respond to a new discussion topic. These extra tweets
and texts are to encourage treatment participants to interact with
other group members about quitting.
Coed treatment groups consist of 20 participants with a mixture
of men and women. However, there are even numbers of men
and women in each coed treatment group, so that buddies can
be of the same gender. Women-only treatment groups have 20
participants consisting of only women. All treatment
interventions (eg, discussion topics) for the coed and
women-only groups are the same. All treatment participants
receive 8 weeks of nicotine patches (1 per day) and their choice
of gum or lozenges (12 per day while on the patch), and
Smokefree.gov quit guides are emailed about every 5 days.
Control Arm
Control participants receive 8 weeks of nicotine patches (1 per
day); their choice of nicotine gum or lozenges (12 per day while
on the patch); and Smokefree.gov quit guides, which are emailed
about every 5 days. Treatment and control groups run parallel
to each other, ie, start at the same time.
Withdrawal
Participants can drop from the study, by request, at any time.
If a participant stops sending tweets to their group, the team
still follows up at the scheduled times unless otherwise
requested, and the participants are still eligible for the gift cards
for completing follow-up assessments.
Mode of Delivery/Communication
The NRT products are provided via mail, but all other
components of the intervention are provided over the internet
or email. Each participant receives log-in information, as well
as all resource guides, automatically via email. Daily reminders
are sent via SMS text messages. If the participant needs to
interact with the study team, they can send an email (a contact
form is available on the study website) or call the staff directly.
The support group is virtually located on Twitter, and
participants only have to log into their accounts to interact with
their support group. Guides that clearly show participants how
to log in and use Twitter are provided and also posted on the
study website.
Outcomes
Primary Outcome
Participants report their use of tobacco products at 1, 3, and 6
months after the quit date (the date they selected to quit
smoking) by answering the following questions: “How many
cigarettes have you smoked,” “How many other tobacco
products have you used,” and “How many times have you used
e-cigarettes since the quit date.” If participants self-report no
tobacco use and no use of NRT, this is confirmed biochemically
using a salivary cotinine test at 3 and 6 months after the quit
date. Participants will complete the salivary test while we
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observe on a webcam (camera on their mobile phone), they take
a picture of the test results, and they text us the picture. If
webcam observation is unfeasible, participants will complete
the salivary test on their own and text us a picture of the results.
We will apply the Russell Standard for sustained abstinence,
allowing five or fewer instances of tobacco use over 6 months.
We will use online self-reported surveys to collect the tobacco
use data.
In our primary (most rigorous) analysis, we will consider a
cotinine-positive test, regardless of source, to be nonabstinent.
In additional analyses, we will code as abstinent those who
assert tobacco abstinence but continue use of US Food and Drug
Administration–approved NRT. In other analyses, we will
consider use of electronic nicotine delivery systems (ENDS;
such as e-cigarettes or vaping), with ENDS users coded first as
nonabstinent and then for comparison as abstinent. Secondary
analyses will examine 3-month (end of treatment) sustained and
bioconfirmed abstinence and 7-day point prevalence abstinence
at 1, 3, and 6 months.
Time Schedule of Enrollment and Participation
Table 1 shows the study flow for each cohort. Enrollment and
allocation to condition occurred first, followed by the 3-month
intervention, with assessments occurring at 1 month, 3 months,
and 6 months.
Table 1. Study flow.
Study period and timepointStudy activity
Close-outPostallocationAllocationEnrollment
Month 6Month 5Month 4Month 3Month 2Month 1Month 0Month 0
Enrollment
✓Eligibility screen
✓Informed consent
✓Verification of email, phone, and webcam
✓Randomization
Treatments
✓✓✓Twitter mobile support group
✓✓✓Nicotine replacement therapy
✓✓✓Emails linked to Smokefree.gov
Assessments
✓✓✓Follow-up surveys
✓✓Saliva tests
Recruitment
All recruitment is done online through advertisements. Primarily,
Facebook ads are purchased to recruit participants. Ads are
designed to target people on Facebook who indicate interest in
smoking or quitting smoking, with additional ZIP code targeting
of black/African American participants and Hispanic/Latino
participants living in high-smoking areas and some limited
targeting of Spanish-English bilingual speakers to increase
participant diversity. People see a study ad on Facebook, and
if they click on the ad, they are brought to the study website,
where they can fill out a brief form indicating interest. In
addition, some free Google Ads (provided through the Google
Grants program to assist nonprofits) appear for the study when
quit-smoking keywords are entered into the Google search
engine. Finally, an ad listed on Smokefree.gov directs traffic to
the study website.
Randomization
Randomization occurs once the targeted number of participants
for a cohort is reached based on the online eligibility screen and
the verification of email, phone, and webcam (camera on mobile
phone) for saliva testing. Participants are randomized to the
treatment or control condition by statistician KD using
deidentifiable ID numbers. The allocation is fully random, with
each person having an equal chance of ending up in the
treatment or control condition. Whether the cohort treatment is
coed or women only is also randomly determined by KD. After
the treatment commences, the condition assignment is not
blinded to participants and the research team; however, during
data collection, the staff members that contact participants (if
participants do not complete follow-up surveys on their own)
are not told the study condition of participants to ensure equal
effort in gathering data. The process of starting a new
treatment/control cohort is repeated every few weeks to a month
until 960 participants are attained (36 treatment/control cohorts
beyond the 20-person pilot).
Consent
As the study is conducted via internet across the continental
United States, rather than in person, a waiver of signed consent
has been obtained. At the beginning of screening, potential
participants receive an information sheet that contains study
information, and they must consent (by clicking yes or no) to
continue with screening.
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Institutional Review Board
The study is under the oversight of the UCI’s and the Stanford
University’s institutional review boards (IRBs). Any requested
changes to the protocol are submitted through these IRBs.
Study History
During 2011 to 2014, we ran an initial evaluation of Tweet2Quit
that tested this mobile support group platform for quitting
smoking, and we observed a self-reported abstinence rate of
40% at 60 days compared with 20% in the control group [34].
This study extends follow-up to 6 months to document sustained
abstinence, uses bio-confirmation to validate self-report, and
incorporates a women-only Tweet2Quit treatment arm. We also
introduce demographically matched buddy pairs for extra
support within the group, tweet streaks to encourage daily dyadic
interactions (daily text messages to participants, showing the
number of days in a row they tweeted other participants without
missing), and low tweet messaging that supplies extra topics
when the number of group tweets is low. We added these
features to the Tweet2Quit intervention because we observed
that tweeting about relevant topics, such as using nicotine
patches and countering roadblocks to quitting, increased the
participants’ chance of achieving abstinence [24].
Revisions
This study is based on the most recent protocol version,
September 2018. During the course of the study, there were no
major study revisions, but we increased the monetary incentives
for completing the outcome assessments to improve response
rates.
Data Collection, Management, and Analysis
Self-assessment follow-up surveys are automatically emailed
to participants by the software program Qualtrics (Provo, Utah)
at 1, 3, and 6 months after a participant’s quit date (the date
they set to quit smoking). These surveys are compliant with the
Checklist for Reporting Results of Internet E-Surveys.
Participants’ responses to the online survey questions are kept
on the Qualtrics server until they are downloaded by the study
team for analysis. When participants do not complete a survey
themselves, the research team reaches out to them via phone to
complete the survey with them, and the research team enters
the data for them into the online Qualtrics survey. The survey
questions assess the effectiveness of the intervention at
promoting abstinence based on participants’ self-reports, and
they also track participants’ self-reported use of NRT and ENDS
products. All participants receive these surveys, along with a
monetary gift card for completion, regardless of condition and
even if the participant does not actively participate in (tweet)
their treatment group.
Statistical Analyses
Dropout rates are examined by condition. Every effort is made
to limit the amount of missing data from survey attrition by
doing persistent follow-up with participants and contacting their
preidentified collaterals (family members and friends) to urge
survey completion. Before analysis, we will examine baseline
predictors of attrition. If it appears that attrition is related to
measured aspects of the participants, we will include those
measures as covariates in the models. Sensitivity analyses will
check that the methods of dealing with missing data do not have
a major impact on the results. We will repeat the attrition
analyses under two different models, one in which the missing
data are assumed to be positive for smoking and one using only
the respondents who did not have missing data. We expect to
find that although estimates may change some, the conclusions
generated by the modeling should not change.
For primary hypothesis testing of sustained abstinence at 6
months, we will use the 6-month postquit date survey (based
on the quit date selected by the participant at the beginning of
the study) and biochemical salivary cotinine verification. To
test the primary aim 1 hypothesis, analyses will compare
sustained abstinence for participants randomized to coed
Tweet2Quit treatment versus control. Sustained abstinence will
be modeled as a function of study arm (coed Tweet2Quit or
control), gender, cohort, and individual using a logistic model
and generalized estimating equations (Proc Genmod in SAS;
SAS Institute Inc, Cary, North Carolina) to account for the
clustering of individuals within cohort. Our statistical methods
will use all the data in parameter estimation. We will test the
coefficient of the study arm or treatment condition parameter
by gender, if there is a treatment condition by gender interaction.
The same type of generalized logistic model, but focusing on
women, will be used to test the primary aim 2 hypothesis, on
whether women will achieve greater 6-month sustained,
bioconfirmed abstinence if randomized to a women-only versus
coed Tweet2Quit treatment group. Secondary hypotheses
concerning sustained abstinence at 3 months (ie, at treatment
end) and point prevalence (prior 7 days) abstinence at 1, 3, and
6 months will be tested using the same modeling approaches.
Exploratory aims will be met by testing our mediational models
of predictors of abstinence. Regression models of each
individual path will be tested. Subsequently, using a structural
equation modeling approach, we will test whether the
relationships between buddy pairs and abstinence, and social
brokers and abstinence, can be accounted for by tie strength or
other network characteristics, with direct paths modeled as well.
Smokefree.gov Collaboration
Whenever treatment or control participants receive our email
with a link to a Smokefree.gov quit guide and click on the link,
their behavior on the Smokefree.gov website, including the
number of page views and time spent, is automatically logged.
Smokefree.gov provides us with these data on usage of their
quit-smoking guides so that we can determine if guide usage
improves abstinence and if the Tweet2Quit treatment affects
guide usage.
Data and Safety Monitoring Board
As the interventions are fairly standard and low-risk, a data
safety monitoring board is not used.
Confidentiality
All collected data are kept on secure online databases that are
password protected with access limited to the study team.
Subject-identifiable data will be retained until publication, at
which point it will be destroyed. At the end of each group,
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Twitter profile pictures (pictures of participants’ faces that we
use to create their study accounts on Twitter) will be destroyed.
Pictures of saliva test results, which do not show
subject-identifiable data, will be kept indefinitely as proof of
abstinence.
Privacy
Privacy is a concern with any study that is conducted online,
especially in a support group that encourages participants to be
open with each other. Although social media is a public
platform, there are Twitter settings that quickly ensure groups
are permanently and completely private. All these privacy
features are turned on to prevent participants from being easily
searched on Twitter or have their tweets seen by their family,
friends, or other people outside the treatment group. Their tweets
are even hidden from other treatment groups in the study.
Participants are further taught how to interact on the Twitter
platform to keep themselves and others safe and the group
private.
Access to Data
UCI will be working with personnel from both the University
of California, San Francisco (UCSF), and Stanford University
in the analysis portion of this study, sharing both the survey
data and the bioconfirmed abstinence data. UCI personnel will
remove all identifiable data from the files before sharing with
the other sites. JP has secured IRB approval from Stanford
University and will be working in collaboration with UCI. No
subject enrollment or data collection has been conducted at
Stanford. Data will be shared between Stanford and UCI
primarily in a deidentifiable fashion, but some datasets may
include minimal identifiable data (eg, Twitter usernames). JP
receives subject-identifiable data from UCI in the event of a
serious adverse event but does not receive identifiable data at
any other time. In sum, both deidentifiable data and identifiable
data will be seen by JP while working from Stanford.
KD will conduct his portion of the study from UCSF; however,
he will not have access to identifiable data. KD assists in
randomizing participants to groups, but he only uses
deidentifiable subject IDs for randomization and data analysis.
KD has no interaction with human subjects. Both JP and KD
will assist in analysis of deidentifiable data.
Dissemination of Data
The study team plans to present the findings at academic
conferences and publish them in peer-reviewed academic
journals. In addition, the team plans to discuss the findings with
government officials such as those affiliated with
Smokefree.gov. Only research team members will be authors
of any papers written, and participant identifiers will be
removed.
Results
Results for Recruitment and Retention
IRB approval of the study began in March 2016, with National
Institutes of Health funding running from March 2016 to March
2021. Recruitment has taken place from November 2016 to
September 2018, and 980 participants have been enrolled.
However, 20 of these participants were part of a pilot group to
pretest the intervention and will not be used in the main
analyses. As part of the randomized controlled trial (n=960),
480 participants have been allocated to the coed treatment
condition, 240 participants have been allocated to the
women-only treatment condition, and 240 participants have
been allocated to the control condition. Table 2 provides the
demographics of these participants.
Table 2. Demographics of participants in the randomized controlled trial by condition.
Control (n=240)Women-only treatment (n=240)Coed treatment (n=480)Intervention
40.439.839.0Mean age (years)
Gender, n (%)
73 (30.42)0 (0)142 (29.58)Male
167 (69.58)240 (100)338 (70.41)Female
Ethnicity, n (%)
197 (82.08)204 (85.0)376 (78.33)White
21 (8.75)22 (9.17)55 (11.46)African American/black
10 (41.67)6 (2.50)21 (4.38)Hispanic/Latino
12 (5.0)8 (3.33)28 (5.83)Other
Only 8 (<1%) participants withdrew from the study, that is, they
requested removal from all intervention emails and texts (eg,
the Smokefree.gov quit guides) and all assessments, and if in a
treatment condition, they dropped out of their Twitter support
group. At 6-month follow-up (the primary outcome measure),
we have collected 896 surveys or 93.3% (896/960), with 56 of
the participants or 5.8% (56/960) lost to follow-up and 8 or <1%
(8/960) who discontinued the intervention (see Multimedia
Appendix 1 for the breakdown at each follow-up). The primary
analysis will compare the focal conditions to assess the
percentages of participants with biometrically verified sustained
abstinence. For this primary analysis, we have collected data
from 437 of the 480 participants (91.0%) in the coed treatment
condition, 226 of the 240 participants (94.2%) in the
women-only treatment condition, and 233 of the 240 participants
(97.1%) in the control condition.
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No serious adverse events have occurred. There have been no
security breaches, but there was a technical error that caused
the feedback texts and tweet streaks to be inaccurate for a few
days in one group. Participants were told about the technical
error and continued to interact normally.
Power Analysis
Sample sizes were selected to have sufficient power to test both
primary hypotheses. For testing the aim 1 hypothesis, a logistic
regression to assess power, based on sustained abstinence
estimates of 20.0% for Tweet2Quit-coed (n=480) versus 8.0%
for usual care-coed (n=240), estimated 98% power at P=.05
and 97% power with 13% (94/720) expected survey attrition.
For testing the aim 2 hypothesis, a logistic regression to assess
power, based on sustained abstinence estimates of 26.0% for
Tweet2Quit-women-only (n=240) versus 14.0% for women in
Tweet2Quit-coed (n=240), estimated 88% power at P=.05 and
83% power with 13% (62/480) expected survey attrition.
Regarding the structural equations models we will use to test
for process effects, the standard fit statistics will be evaluated.
We will not rely on the Chi-square statistic as it is sensitive to
sample size. If we find poor fit in this exploratory analysis, we
will examine the individual parts of the model to determine
what aspects indicate poor measurement or relationships and
revise the model accordingly.
Discussion
Principal Findings
This study builds on the encouraging effects found with the
Tweet2Quit quit-smoking platform, which was developed and
tested from 2011 to 2014. Current extensions include an analysis
of 6-month sustained bioconfirmed abstinence and a comparison
of women-only and coed treatment groups. Existing
quit-smoking programs utilize Twitter groups or daily texts, but
our program combines these ideas and creates private
Web-based groups that connect people across the United States
to receive peer support and daily messages for quitting smoking.
We will test if after 6 months the participants attain sustained
abstinence. Participants in the coed control condition and the
coed Tweet2Quit condition will be compared. In addition,
women participants in the coed Tweet2Quit condition and the
women-only Tweet2Quit condition will be compared.
Strengths and Limitations
As only those who regularly use social media can participate
in our Tweet2Quit program, a concern could be raised about
reaching the relevant US population. However, this concern is
mitigated by the fact that 73% of US adults who are online use
social media, so we feel that we can reach the majority of the
online population [12].
In our study, there is also the concern that, because participants
know which condition they are in, if placed into the control
rather than a treatment condition, they may withdraw from the
study or its assessments. However, less than 1% of participants
withdrew from the study. In addition, we have a team follow-up
with all the participants who do not complete a survey on their
own to gather the data. As a result, we have attained similar
response rates across the study conditions and 90% or higher
response rates overall.
Conclusions
If the Tweet2Quit treatment is found to be efficacious, it will
provide an easily accessible program for anyone nationwide to
help them quit smoking and stay smoke free. Furthermore, the
intervention can be easily replicated in other health contexts
because the Twitter platform can be used free of charge in nearly
the entire world.
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